Guest guest Posted October 4, 2005 Report Share Posted October 4, 2005 http://www.emediawire.com/releases/2005/10/emw293216.htm Guess who is sending out press releases? Nelly (...)Yesterday, the Nobel Prize Committee issued a press release announcing the 2005 Nobel Prize in Medicine; stating, inter alia, “Many diseases in humans such as Crohn's disease, ulcerative colitis, rheumatoid arthritis and atherosclerosis are due to chronic inflammation. The discovery that one of the most common diseases of mankind, peptic ulcer disease, has a microbial cause, has stimulated the search for microbes as possible causes of other chronic inflammatory conditions.”It should be noted that Sarcoidosis is a chronic inflammatory condition, and that Dr. Trevor Marshall is no relation to Dr. Barry Marshall, although they are both alumni of the University of Western Australia and trained in the same QEII Medical Center in Perth, Western Australia, during the same time period (early ‘80s).(see URL http://nobelprize.org/medicine/laureates/2005/press.html)Supporting materials for journalists:1. PDF versions of the three ‘Orphan Product’ applications to the FDA can be reviewed at URLs http://AutoimmunityResearch.org/orphan-app-benicar.pdf http://AutoimmunityResearch.org/orphan-app-clindy.pdf http://AutoimmunityResearch.org/orphan-app-mino.pdf2. A complimentary DVD of the foundation’s conference session “What is Cure,” where the above patients described their recoveries, is available upon request.3. “Before” and “After” photographs of recovered patients, and contact details for interviews, are available from the foundation and from http://AutoimmunityResearch.org/presskits/3oct05.htmGeneral Foundation Email: Foundation at AutoimmunityResearch.org Foundation Website: http://www.AutoimmunityResearch.org### Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.